Literature DB >> 2630567

Human macrophage-mediated cytotoxicity of Schistosoma mansoni. Functional and structural features of the effector cells.

B J Cottrell1, C Pye, A M Glauert, A E Butterworth.   

Abstract

Human monocytes were purified from peripheral blood and cultured in vitro on hydrophobic membranes. Such cells developed into mature tissue-type macrophages after approximately 1 week in culture. During this maturation period the macrophages developed a potent cytotoxic mechanism whereby they could kill the schistosomula of Schistosoma mansoni in standard in vitro cytotoxicity assays. Cytological and ultrastructural studies of the cells grown in vitro indicated that macrophages developed many of the classical histological and ultrastructural features of 'activated' cells with ruffled plasma membranes and significant increases in rough endoplasmic reticulum and Golgi vesicles. Effective cytotoxicity depended upon contact of the effector cells and their parasite target. Further, experiments using metabolic inhibitors indicated that cytotoxicity was dependent upon protein synthesis. Initial results point to the macrophage factor being distinct from some of the better-characterised macrophage secretory products such as tumour necrosis factor, proteases and products of oxygen metabolism.

Entities:  

Mesh:

Year:  1989        PMID: 2630567     DOI: 10.1242/jcs.94.4.733

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  2 in total

1.  Oligoesculin fraction induces anti-tumor effects and promotes immune responses on B16-F10 mice melanoma.

Authors:  Imen Mokdad Bzeouich; Nadia Mustapha; Aicha Sassi; Kamel Ghedira; Mohamed Ghoul; Latifa Chebil; José Luis; Leila Chekir-Ghedira
Journal:  Tumour Biol       Date:  2016-03-10

2.  Freshly isolated and cultured human monocytes obtained by plasmapheresis kill schistosomula of Schistosoma mansoni.

Authors:  M Lehn; C P Chiang; H G Remold; J R Swafford; J P Caulfield
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.